Published in

Taylor and Francis Group, Expert Opinion on Drug Safety, 4(13), p. 497-510, 2014

DOI: 10.1517/14740338.2014.888413

Links

Tools

Export citation

Search in Google Scholar

Axitinib safety in metastatic renal cell carcinoma: suggestions for daily clinical practice based on case studies

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO